Literature DB >> 12495885

[Usefulness of the French DRG based information system (PMSI) in the measurement of cancer activity in a multidisciplinary hospital: the Hospices Civils de Lyon].

Anne-Marie Schott1, Touria Hajri, Cyrille Colin, François Grateau, François N Gilly, Etienne Tissot, Cécile Couchoud, Catherine Morestin, Véronique Trillet-Lenoir.   

Abstract

Measuring the burden of cancer activity in big teaching multidisciplinary hospitals becomes a real challenge in France for organizational, quality of care and economic reasons. At the "Hospices Civils de Lyon" University Hospital in France, we have chosen to face this question by using the french DRG based information system called PMSI. It allows to identify hospital stays related to cancer care through the use of an algorithm based on selected ICD 10 codes for hospital stay. We then estimate the proportion of patients concerned by cancer and classify hospital stays and patients according to various epidemiological and clinical parameters. The results for the year 1999 taken as an example showed that 43,883 out of 293,827 (15%) of hospital stays were related with a diagnostic of cancer, corresponding to 12,777 different patients. The concordance study on 154 patients between the data from the electronic PMSI files and medical paper records showed a 97% concordance for cancer diagnosis and 93% for the precise type of tumor. In absence of hospital based cancer registries, the PMSI data base gives an accurate source of information for cancer burden and provides many potential applications in defining hospital policies for cancer management and resource allocations.

Entities:  

Mesh:

Year:  2002        PMID: 12495885

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  French claims data as a source of information to describe cancer incidence: predictive values of two identification methods of incident prostate cancers.

Authors:  Chantal Marie Couris; Arnaud Seigneurin; Sabiha Bouzbid; Muriel Rabilloud; Paul Perrin; Xavier Martin; Cyrille Colin; Anne-Marie Schott
Journal:  J Med Syst       Date:  2006-12       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.